PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 5, 2026PLoS ONE0 citationsOpen Access

The relationship between maternal glucose concentrations, gestational diabetes mellitus, placental weight, and placental vascular malperfusion lesions: A retrospective study of a U.S. pregnancy cohort

View Full Paper
AAAmrita ArcotKGKelly GallagherJGJeffery GOLDSTEIN

Key Points

  • This research aimed to explore the connections between glucose levels, gestational diabetes, and related placental characteristics.
  • Conducted a secondary analysis of medical records from singleton placentas submitted to pathology.
  • Analyzed data from 11,585 cases at Northwestern Memorial Hospital between 2011 and 2022.
  • Classified glucose challenge test concentrations into pass (<140 mg/dL) and fail (≥140 mg/dL) groups, along with GDM diagnosis.
  • Employed linear and Poisson regression models to assess associations while adjusting for various maternal characteristics.
  • 17% of placentas were in the fail GCT/no GDM group while 5% were diagnosed with GDM.
  • Mean placental weight was 13.6 grams heavier in the fail GCT/no GDM group and 22.0 grams heavier in the GDM group compared to pass GCT/no GDM.
  • Patients with GDM had a 36% increased risk of delayed villous maturation compared to pass GCT/no GDM, with no significant difference in other lesions.

Abstract

Background Gestational diabetes mellitus (GDM) is associated with increased placental weight and the presence of placental malperfusion lesions, likely related to high blood glucose. The relationship between high glucose without overt GDM, and placental characteristics is not well understood. Objective To examine the relationships between glucose challenge test (GCT) concentrations, GDM, and placental characteristics associated with GDM. Methods We conducted a secondary analysis of medical record data from singleton placentas sent to pathology at Northwestern Memorial Hospital (2011–2022; n = 11,585). Placentas were submitted based on standard clinical protocol. Data included maternal demographic variables, GCT concentrations, GDM diagnosis, placental weight, and vascular malperfusion lesions (accelerated villous maturation, increased syncytial knots, delayed villous maturation, and increased perivillous fibrin deposition). We classified GCT <140 mg/dL as pass and ≥140 mg/dL as fail. GDM was classified by diagnosis. We categorized glucose groups into pass GCT/no GDM , fail GCT/no GDM , and GDM . We used linear and Poisson (due to non-convergence of log-binomial) regression models to examine the association between GCT concentrations or groups with placental outcomes, adjusting for maternal age, race and ethnicity, parity, gestational age at delivery, and infant sex. Results Of placentas sent to pathology, 17% were in the fail GCT/no GDM group and 5% were in the GDM group. Compared to the pass GCT/no GDM group, the adjusted mean placental weight was heavier by 13.6 grams 95% CI: 8.8, 18.3 in the fail GCT/no GDM and 22.0 grams 13.8, 30.2 in the GDM group. Patients diagnosed with GDM had a 36% 2%, 81% increased adjusted risk of delayed villous maturation compared to the pass GCT/no GDM . The risk of the other lesions (accelerated villous maturation, increased syncytial knots, and increased perivillous fibrin deposition) was not significantly different between groups. Conclusion GDM and high glucose concentrations without GDM were associated with heavier placentas. Patients with GDM had a higher risk of delayed villous maturation, but risk of other placental lesions was similar.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Arcot et al. (2026) studied this question.

synapsesocial.com/papers/69a91d7cd6127c7a504c0492https://doi.org/10.1371/journal.pone.0325415
Ask AI
Helpful
Bookmark
Share
View Full Paper